Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune complex detection by immunofluorescence on polymorphonuclear leucocytes.

J W Steffelaar, F J Ten Kate, M Nap

    Clinical and Experimental Immunology
    |March 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The SpaTemp cohort: 168 nondysplastic Barrett's esophagus surveillance patients with and without progression to early neoplasia to evaluate the distribution of biomarkers over space and time.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2020
    Same author

    Correction to: Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology.

    Diagnostic pathology·2019
    Same author

    Comparative analysis of confocal microscopy on fresh breast core needle biopsies and conventional histology.

    Diagnostic pathology·2019
    Same author

    Digital microscopy as valid alternative to conventional microscopy for histological evaluation of Barrett's esophagus biopsies.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2017
    Same author

    Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).

    European journal of cancer (Oxford, England : 1990)·2017
    Same author

    Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2013

    Systemic lupus erythematosus (SLE) patients

    Area of Science:

    • Immunology
    • Rheumatology
    • Cell Biology

    Background:

    • Polymorphonuclear leucocytes (PMN) play a role in immune complex diseases.
    • Systemic lupus erythematosus (SLE) is characterized by autoantibodies and immune complex deposition.
    • Understanding PMN interactions with immune complexes is crucial for SLE pathogenesis.

    Purpose of the Study:

    • To investigate the presence and origin of immunoglobulin (Ig) inclusions in PMN from SLE patients.
    • To assess the role of in vitro phagocytosis in PMN Ig uptake.
    • To determine if artificial immune complexes can be detected by PMN.

    Main Methods:

    • Isolation of PMN from SLE patients and healthy donors.
    • Incubation of PMN with SLE sera and artificial immune complexes (HBsAg/anti-HBs).

    Related Experiment Videos

  • Use of monoiodine acetic acid (MIAA) to inhibit in vitro phagocytosis.
  • Immunofluorescence technique to detect IgG, IgM, and HBsAg in PMN.
  • Main Results:

    • PMN from SLE patients' defibrinated blood showed high levels of Ig inclusions (up to 80%).
    • Inhibition of in vitro phagocytosis with MIAA reduced Ig inclusions in defibrinated blood PMN to levels seen in heparinized blood.
    • Normal PMN incubated with SLE sera showed Ig inclusions, which were abolished by MIAA.
    • Artificial immune complexes were detected by PMN, with detection varying by antigen/antibody ratio.

    Conclusions:

    • Ig inclusions in PMN from heparinized SLE blood are primarily due to in vivo phagocytosis of circulating immune complexes.
    • In vitro phagocytosis experiments confirm the presence of immune complexes in SLE sera.
    • PMN can phagocytose artificial immune complexes, with efficiency dependent on the antigen-antibody ratio.